ASAP1, a Gene at 8q24, Is Associated with Prostate Cancer Metastasis
- 1 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (11) , 4352-4359
Abstract
Metastatic prostate cancer is a terminal disease, and the development of reliable prognostic tools and more effective therapy is critically important for improved disease survival and management. This study was aimed at identifying genes that are differentially expressed in metastatic and nonmetastatic prostate cancer cells and, as such, could be critical in the development of metastasis. Long-SAGE analysis was used to compare a transplantable human metastatic prostate cancer subline, PCa1-met, with a nonmetastatic counterpart, PCa2. Both sublines were developed from a patient's prostate cancer specimen via subrenal capsule grafting and subsequent orthotopic implantation into SCID mice. Among various differentially expressed genes identified, ASAP1, an 8q24 gene encoding an ADP-ribosylation factor GTPase-activating protein not previously associated with prostate cancer, was up-regulated in the metastatic subline as confirmed by quantitative real-time PCR. Immunohistochemistry of xenograft sections showed that cytoplasmic ASAP1 protein staining was absent or weak in benign tissue, significantly stronger in nonmetastatic PCa2 tissue, and strongest in PCa1-met tissue. In clinical specimens, ASAP1 protein staining was elevated in 80% of primary prostate cancers and substantially higher in metastatic lesions compared with benign prostate tissue. Moreover, additional ASAP1 gene copies were detected in 58% of the primary prostate cancer specimens. Small interfering RNA–induced reduction of ASAP1 protein expression markedly suppressed in vitro PC-3 cell migration (∼50%) and Matrigel invasion (∼67%). This study suggests that the ASAP1 gene plays a role in prostate cancer metastasis and may represent a therapeutic target and/or biomarker for metastatic disease. [Cancer Res 2008;68(11):4352–9]Keywords
This publication has 32 references indexed in Scilit:
- Multiple regions within 8q24 independently affect risk for prostate cancerNature Genetics, 2007
- Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasisThe Prostate, 2006
- The mighty mouse: genetically engineered mouse models in cancer drug developmentNature Reviews Drug Discovery, 2006
- Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related ChangesClinical Cancer Research, 2006
- 8q Gain Is an Independent Predictor of Poor Survival in Diagnostic Needle Biopsies from Prostate Cancer SuspectsClinical Cancer Research, 2006
- An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor lineLaboratory Investigation, 2005
- Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?Journal of Molecular Medicine, 2005
- Development and characterization of efficient xenograft models for benign and malignant human prostate tissueThe Prostate, 2005
- Mapping and Gene Expression Profile of the Minimally Overrepresented 8q24 Region in Prostate CancerThe American Journal of Pathology, 2002
- The initiation of cell division in a contact‐inhibited mammalian cell lineJournal of Cellular and Comparative Physiology, 1965